ISAR-SAFE: a randomized, double-blind, placebo-controlled trial of 6 vs. 12 months of clopidogrel therapy after drug-eluting stenting (Q38417372)
Jump to navigation
Jump to search
scientific article published on 23 January 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | ISAR-SAFE: a randomized, double-blind, placebo-controlled trial of 6 vs. 12 months of clopidogrel therapy after drug-eluting stenting |
scientific article published on 23 January 2015 |
Statements
1 reference
ISAR-SAFE: a randomized, double-blind, placebo-controlled trial of 6 vs. 12 months of clopidogrel therapy after drug-eluting stenting (English)
1 reference
Stefanie Schulz-Schüpke
1 reference
Albert Schömig
1 reference
Adnan Kastrati
1 reference
Karl-Ludwig Laugwitz
1 reference
Heribert Schunkert
1 reference
Franz-Josef Neumann
1 reference
Walter Desmet
1 reference
Tareq Ibrahim
1 reference
Christian Hengstenberg
1 reference
Dominick J Angiolillo
1 reference
Jurrien M Ten Berg
1 reference
Yaling Han
1 reference
Tom Adriaenssens
1 reference
Ralph Tölg
1 reference
Melchior Seyfarth
1 reference
Michael Maeng
1 reference
Bernhard Zrenner
1 reference
Claudius Jacobshagen
1 reference
Harald Mudra
1 reference
Eberhard von Hodenberg
1 reference
Jochen Wöhrle
1 reference
Barbara von Merzljak
1 reference
Nonglag Rifatov
1 reference
Tanja Morath
1 reference
Antonia Feuchtenberger
1 reference
Paul W A Janssen
1 reference
Christian Valina
1 reference
Yi Li
1 reference
Mohamed Abdel-Wahab
1 reference
Klaus Tiroch
1 reference
Isabell Bernlochner
1 reference
Marcus Fischer
1 reference
Intracoronary Stenting and Antithrombotic Regimen: Safety And EFficacy of 6 Months Dual Antiplatelet Therapy After Drug-Eluting Stenting (ISAR-SAFE) Trial Investigators
1 reference
23 January 2015
1 reference
1 reference
Identifiers
1 reference